What Marrow Does to Bone
Author:
- Lawrence G. RaiszLRLawrence G. Raisz
- 11 June 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (24) , 1485-1486
Abstract
Bone-marrow formation is a remarkable feat. During fetal life, hematopoietic cells leave their soft beds in the liver and spleen and excavate a safer home inside the skeleton. Hence, these cells must have the ability to migrate to the endosteum and subsequently to remove the calcified tissue that fills most of the available space in developing bone. The bone-resorbing cells, which accomplish the latter task, have a different lineage from the osteoblasts', which initially form bone.1 Marrow formation is probably initiated by invasion of vessels that make a path for blood-borne osteolytic cells. The osteolytic cells are derived from monocytic . . .Keywords
This publication has 10 references indexed in Scilit:
- Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- lDirect Stimulation of Bone Resorption by Epidermal Growth Factor*Endocrinology, 1980
- An assay for osteoclast-activating factor (OAF) in biological fluids: Detection of OAF in the serum of myeloma patientsCellular Immunology, 1980
- Glucose homeostasis in children with severe cyanotic congenital heart diseaseThe Journal of Pediatrics, 1979
- Prostaglandin synthesis by fetal rat bone in vitro: Evidence for a role of prostacyclinProstaglandins, 1979
- Histogenesis of bone cellsCalcified Tissue International, 1978
- Resorbing bone is chemotactic for monocytesNature, 1978
- Thalassemic OsteoarthropathyAnnals of Internal Medicine, 1978
- Prostaglandins and Hypercalcemic StatesAnnual Review of Medicine, 1978
- Effect of osteoclast activating factor from human leukocytes on bone metabolism.Journal of Clinical Investigation, 1975